Precision Oncology’s Messerschmidt on Protocol Development in PharmaVOICE

Precision Oncology’s Dr. Gerald Messerschmidt discusses clinical protocol development with Denise Myshko for PharmaVOICE.

For the complete article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics, adaptive clinical trial execution to regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.